Repros Therapeutics (RPRX) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.41 -0.88%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q3 EPS of ($0.32), $0.07 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS cuts KOSPI target by nearly 10% to reflect higher rates
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
